Advertisement

Hemofiltration pp 115-117 | Cite as

Selection of Patients for Hemofiltration

  • S. Glabman
  • A. Lauer
Chapter

Abstract

During the past 25 years a number of modalities have been developed for the treatment of end-stage renal disease (ESRD). In addition to conventional hemodialysis (HD) and transplantation, continuous ambulatory peritoneal dialysis (CAPD) and hemofiltration (HF) have become alternatives for the treatment of ESRD. HF has become particularly popular in Europe. The purpose of this chapter is to identify those types of patients who might be best suited for chronic HF.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mäher JF, Schreiner GE (1965) Hazards and complications of dialysis. N Engl J Med 270: 370–377CrossRefGoogle Scholar
  2. 2.
    Henderson LW (1980) Symptomatic hypotension during hemodialysis. Kidney Int 170: 571–576CrossRefGoogle Scholar
  3. 3.
    Quellhorst EA, Schoenemann B (1979) A controlled study to compare hemodialysis and hemofiltration treatment in patients with chronic renal failure. In 12th annual contractors conference — Artifical kidney, chronic uremia program. National Institute of Arthritis, Metabolism and Digestive Disease, January 1979Google Scholar
  4. 4.
    Henderson LW, San Filippo ML, Stone RA (1979) Comparison of hemodialysis and hemofiltration. In 12th annual contractors conference — Artificial kidney, chronic uremia program. National Institute of Arthritis, Metabolism and Digestive Disease, January 1979Google Scholar
  5. 5.
    Bosch JP, Ponti R, Glabman S, Lauer A (to be published) Sodium fluxes in hemodialysis.Google Scholar
  6. 6.
    Bosch JP, Glabman S, von Albertini B, Geronemus R, Kahn J, Goldstein MH, Kupfer S (1979) Comparison of hemofiltration and ultrafiltration plus hemodialysis to conventional hemodialysis. In 12th annual contractors conference — Artificial kidney, chronic uremia program. National Institute of Arthritis, Metabolism and Digestive Disease, January 1979Google Scholar
  7. 7.
    Jahn H, Schohn D, Gulberg C, Schmitt R (1982) Hemodynamic long-term effects of hemofiltration on dialysis and drug resistant hypertension. Contrib Nephrol 32: 61–68PubMedGoogle Scholar
  8. 8.
    Schaefer K, Herruth D, Gulberg CA, Asmus G, Hufler M, Offerman G, Cremer H, Heuch CC, Ritz E (1978) Chronic hemofiltration: A critical evaluation of a new method for the treatment of blood. J Soc Artif Organs 2: 386–394CrossRefGoogle Scholar
  9. 9.
    Bosch JP, Glabman S, Geronemus R, Constantiner A, von Albertini B (1981) Effect of long-term hemodialysis and hemofiltration on intact PTH and C-Terminal PTH (Abstr). Am Soc Nephrol 37 AGoogle Scholar
  10. 10.
    DeFronzo R (1984) Glucose and insulin metabolism. In: Massry S, Glassock R (eds) Textbook of nephrology. Williams and Wilkins, Baltimore, pp 769–775Google Scholar
  11. 11.
    Kishimoto T, Ezuki K, Yamagumi S, Mackawa M (1982) Glucose tolerance and erythrocyte insulin receptors in undialyzed patients and patients on maintenance hemodialysis and hemofiltration. Contrib Nephrol 32: 97–110PubMedGoogle Scholar
  12. 12.
    Brunzell J, Goldberg A (1984) Hyperlipidemia. In: Massry S, Glassock R (eds) Textbook of nephrology. Williams and Wilkins, Baltimore, pp 775–778Google Scholar
  13. 13.
    Fuchs C, Armstrong VW, Cremer P, Henning HV, Wieland H, Quellhorst E, Seidel D (1982) An investigation of the lipoprotein profiles of patients on hemofiltration as compared to those on hemodialysis and intermittent peritoneal dialysis. Contrib Nephrol 32: 92–96PubMedGoogle Scholar
  14. 14.
    Bosch JP, Glabman S, Moutousis G, Belledonne M, von Albertini B, Kahn T (1984) Carbon dioxide removal in acetate hemodialysis: effect on acid-base balance. Kidney Int 25: 830–837PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • S. Glabman
  • A. Lauer

There are no affiliations available

Personalised recommendations